NCT04729764 Evaluation the Safety and Tolerance of GP681 Tablets in Healthy Subjects Status COMPLETED Phase PHASE1
NCT04712539 Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients Status RECRUITING Phase PHASE2
NCT04695717 This Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in Vietnam Status COMPLETED Phase PHASE3
NCT04678271 Assessment, Feedback, Incentive, Exchange (AFIX OB) A Customizable Quality Improvement Intervention to Increase Maternal Vaccine Uptake Status COMPLETED Phase NA
NCT04672577 Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and Malaria Status NOT_YET_RECRUITING Phase N/A
NCT04664075 Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19) Status TERMINATED Phase N/A
NCT04663776 Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-Based Study Platform Status COMPLETED Phase N/A
NCT04626622 Kagocel® for the Prevention of ARVI and Influenza in Young People Status COMPLETED Phase N/A
NCT04622592 Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and Older Status COMPLETED Phase PHASE1/PHASE2
NCT04613206 High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04611061 Kagocel® for the Prevention of ARVI and Influenza in Adults Health Care Workers Status COMPLETED Phase N/A
NCT04610047 Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness Status COMPLETED Phase PHASE2
NCT04603989 A Study of HNC042 in Healthy Chinese Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics Status COMPLETED Phase PHASE1
NCT04579250 Dose, Safety, Tolerability and Immunogenicity of an Influenza H10 Stabilized Stem Ferritin Vaccine, VRC-FLUNPF0103-00-VP, in Healthy Adults Status COMPLETED Phase PHASE1
NCT04576702 Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults Status COMPLETED Phase PHASE2
NCT04570904 Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness Status COMPLETED Phase N/A
NCT04548518 Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Split Virion Influenza Vaccine, in Healthy Thai Elderly Status UNKNOWN Phase PHASE3